Pulse Biosciences
PLSE
50 hedge funds and large institutions have $53.9M invested in Pulse Biosciences in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 4 closing their positions.
246% more capital invested
Capital invested by funds: $15.6M → $53.9M (+$38.4M)
211% more call options, than puts
Call options by funds: $3.54M | Put options by funds: $1.14M
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
16% more funds holding
Funds holding: 43 → 50 (+7)
1.06% more ownership
Funds ownership: 7.04% → 8.1% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.19M |
| 2 |
BlackRock
New York
|
+$729K |
| 3 |
Morgan Stanley
New York
|
+$446K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$237K |
| 5 |
Jane Street
New York
|
+$233K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$288K |
| 2 |
Millennium Management
New York
|
-$192K |
| 3 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$170K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$105K |
| 5 |
GAM
Griffin Asset Management
New York
|
-$105K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Renaissance Technologies
New York
| – | -$288K | -71,500 | Closed |
|
|
52
Millennium Management
New York
| – | -$192K | -47,754 | Closed |
|
|
LCS
53
Levin Capital Strategies
New York
| – | -$80.4K | -19,939 | Closed |
|
54
Squarepoint
New York
| – | -$78.7K | -19,524 | Closed |
|
PLSE Hedge Fund Activity: Q4 2023 in Review
50 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2023, worth a combined $53.9M — up 246% from $15.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new PLSE positions and 4 closed out — a net gain of 7 holders — while 17 added to existing stakes and 12 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.19M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $288K sold.
- 50 institutional investors held Pulse Biosciences (PLSE) as of Q4 2023, up from 43 in Q3 2023.
- Funds reported $53.9M of Pulse Biosciences stock for Q4 2023, up 246% quarter-over-quarter.
- 11 funds opened new Pulse Biosciences positions in Q4 2023 and 4 closed out, a net change of +7 holders.
- The largest Pulse Biosciences buyer in Q4 2023 was Vanguard Group, an estimated $2.19M added.
- The largest Pulse Biosciences seller in Q4 2023 was Renaissance Technologies, an estimated $288K sold.
Based on aggregated 13F filings for Q4 2023.